{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:42:48Z","timestamp":1767148968937,"version":"build-2238731810"},"update-to":[{"DOI":"10.1016\/j.purol.2018.08.015","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000}}],"reference-count":49,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.purol.2018.08.015","type":"journal-article","created":{"date-parts":[[2018,10,27]],"date-time":"2018-10-27T01:23:44Z","timestamp":1540603424000},"page":"S175-S193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S","title":["RETRACTED: Recommandations fran\u00e7aises du Comit\u00e9 de Canc\u00e9rologie de l\u2019AFU \u2014 Actualisation 2018\u20142020\u00a0: tumeur de la surr\u00e9nale"],"prefix":"10.1016","volume":"28","author":[{"given":"P.-H.","family":"Savoie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Murez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Fl\u00e9chon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"S\u00e8be","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Rocher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Camparo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Morel-Journel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Ferretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"M\u00e9jean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.purol.2018.08.015_bib0250","first-page":"S167","article-title":"[Ccafu's contribution to the French National Cancer Institute's Reference Frame: adrenal malignant Tumors]","volume":"23","author":"Sebe","year":"2013","journal-title":"Prog Urol"},{"key":"10.1016\/j.purol.2018.08.015_bib0255","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jacr.2017.05.001","article-title":"Management of incidental adrenal masses: a white paper of the acr incidental findings Committee","volume":"14","author":"Mayo-Smith","year":"2017","journal-title":"J Am Coll Radiol"},{"key":"10.1016\/j.purol.2018.08.015_bib0260","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.2214\/AJR.10.4547","article-title":"Adrenal imaging","volume":"194","author":"Blake","year":"2010","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.purol.2018.08.015_bib0265","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2214\/AJR.07.2799","article-title":"The incidental adrenal mass on ct: prevalence of adrenal disease in 1049\u00a0consecutive adrenal masses in patients with no known malignancy","volume":"190","author":"Song","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.purol.2018.08.015_bib0270","doi-asserted-by":"crossref","DOI":"10.1530\/EJE-18-0608","article-title":"European Society of endocrinology clinical practice guidelines on the management of adrenocortical carcinoma in adults, in collaboration with The European Network For the study of adrenal tumors","author":"Fassnacht","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.purol.2018.08.015_bib0275","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.amjsurg.2010.04.012","article-title":"Malignant pheochromocytoma: a review","volume":"201","author":"Harari","year":"2011","journal-title":"Am J Surg"},{"key":"10.1016\/j.purol.2018.08.015_bib0280","doi-asserted-by":"crossref","first-page":"264","DOI":"10.20945\/2359-3997000000033","article-title":"What determines mortality in malignant pheochromocytoma? \u2013 Report of a case with eighteen-year survival and review of the literature","volume":"62","author":"Andrade","year":"2018","journal-title":"Arch Endocrinol Metab"},{"key":"10.1016\/j.purol.2018.08.015_bib0285","doi-asserted-by":"crossref","first-page":"E409","DOI":"10.1016\/j.jviscsurg.2011.07.003","article-title":"Pheochromocytoma and abdominal paraganglioma","volume":"148","author":"Renard","year":"2011","journal-title":"J Visc Surg"},{"key":"10.1016\/j.purol.2018.08.015_bib0290","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jviscsurg.2014.07.002","article-title":"Management of adrenal incidentaloma","volume":"151","author":"Menegaux","year":"2014","journal-title":"J Visc Surg"},{"key":"10.1016\/j.purol.2018.08.015_bib0295","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jacr.2010.06.013","article-title":"Managing incidental findings on abdominal CT: white paper of the ACR incidental findings committee","volume":"7","author":"Berland","year":"2010","journal-title":"J Am Coll Radiol"},{"key":"10.1016\/j.purol.2018.08.015_bib0300","doi-asserted-by":"crossref","first-page":"R111","DOI":"10.1530\/EJE-14-0113","article-title":"Therapy of endocrine disease: treatment of malignant pheochromocytoma and paraganglioma","volume":"171","author":"Baudin","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.purol.2018.08.015_bib0305","article-title":"Management of incidental adrenal tumours","volume":"360","author":"Hanna","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.purol.2018.08.015_bib0310","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society Of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the study of adrenal tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"Suppl 7","key":"10.1016\/j.purol.2018.08.015_bib0315","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mds231","article-title":"Adrenal cancer: ESMO clinical practice guidelines for diagnosis treatment and follow-up","volume":"23","author":"Berruti","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.purol.2018.08.015_bib0320","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.ejca.2011.07.016","article-title":"Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status","volume":"48","author":"Eisenhofer","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.purol.2018.08.015_bib0325","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s12672-015-0224-3","article-title":"Diagnostic value of urinary steroid profiling in the evaluation of adrenal tumors","volume":"6","author":"Kerkhofs","year":"2015","journal-title":"Horm Cancer"},{"key":"10.1016\/j.purol.2018.08.015_bib0330","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.surg.2004.05.058","article-title":"Should pheochromocytoma size influence surgical approach?. A comparison of 90\u00a0malignant and 60\u00a0benign pheochromocytomas","volume":"136","author":"Shen","year":"2004","journal-title":"Surgery"},{"key":"10.1016\/j.purol.2018.08.015_bib0335","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1148\/radiol.2342031876","article-title":"Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT","volume":"234","author":"Szolar","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/j.purol.2018.08.015_bib0340","doi-asserted-by":"crossref","first-page":"W109","DOI":"10.2214\/AJR.17.19103","article-title":"Utility Of intermediate-delay washout CT images for differentiation of malignant and benign adrenal lesions: a multivariate analysis","volume":"211","author":"Ng","year":"2018","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.purol.2018.08.015_bib0345","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/PAS.0b013e318190d12e","article-title":"Observer variation in the application of the pheochromocytoma of the adrenal gland scaled score","volume":"33","author":"Wu","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.purol.2018.08.015_bib0350","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/bjs.10414","article-title":"European Society of endocrine surgeons (ESES) and European Network for the study of adrenal tumours (ENSAT) recommendations for the surgical management of adrenocortical carcinoma","volume":"104","author":"Gaujoux","year":"2017","journal-title":"Br J Surg"},{"key":"10.1016\/j.purol.2018.08.015_bib0355","article-title":"Chemical shift imaging for evaluation of adrenal masses: a systematic review and meta-analysis","author":"Platzek","year":"2018","journal-title":"Eur Radiol"},{"key":"10.1016\/j.purol.2018.08.015_bib0360","first-page":"401","article-title":"[Adrenocortical carcinoma: update in 2014]","volume":"43","author":"Libe","year":"2014","journal-title":"Presse Med"},{"key":"10.1016\/j.purol.2018.08.015_bib0365","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fcell.2015.00045","article-title":"Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatment","volume":"3","author":"Libe","year":"2015","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.purol.2018.08.015_bib0370","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00000478-200205000-00002","article-title":"Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100\u00a0cases","volume":"26","author":"Thompson","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.purol.2018.08.015_bib0375","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.lpm.2014.02.002","article-title":"[Update In Adrenal Imaging]","volume":"43","author":"Tenenbaum","year":"2014","journal-title":"Presse Med"},{"key":"10.1016\/j.purol.2018.08.015_bib0380","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0033","article-title":"European Society of endocrinology clinical practice guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma","volume":"174","author":"Plouin","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.purol.2018.08.015_bib0385","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s00259-012-2215-8","article-title":"Eanm 2012\u00a0guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma","volume":"39","author":"Taieb","year":"2012","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.purol.2018.08.015_bib0390","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.purol.2018.08.015_bib0395","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ando.2008.09.003","article-title":"Exploration and management of adrenal incidentalomas. French Society Of Endocrinology Consensus","volume":"69","author":"Tabarin","year":"2008","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/j.purol.2018.08.015_bib0400","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrendo.2010.235","article-title":"Adrenocortical carcinoma: a clinician's update","volume":"7","author":"Fassnacht","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.purol.2018.08.015_bib0405","doi-asserted-by":"crossref","first-page":"E161","DOI":"10.1210\/jc.2010-0653","article-title":"High diagnostic and prognostic value of steroidogenic factor-1\u00a0expression in adrenal tumors","volume":"95","author":"Sbiera","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.purol.2018.08.015_bib0410","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ecl.2015.03.001","article-title":"Endocrine tumor board of Gustave R. Adrenocortical carcinoma","volume":"44","author":"Baudin","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.purol.2018.08.015_bib0415","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/cncr.24030","article-title":"Limited prognostic value of the 2004\u00a0International Union against cancer staging classification for adrenocortical carcinoma: proposal for a revised TNM classification","volume":"115","author":"Fassnacht","year":"2009","journal-title":"Cancer"},{"issue":"Spec No 1","key":"10.1016\/j.purol.2018.08.015_bib0420","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.annpat.2008.09.010","article-title":"[Pheochromocytoma and the diagnosis of malignancy: recent data and the role of the pathologist]","volume":"28","author":"Patey","year":"2008","journal-title":"Ann Pathol"},{"key":"10.1016\/j.purol.2018.08.015_bib0425","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/er.2013-1029","article-title":"Adrenocortical Carcinoma","volume":"35","author":"Else","year":"2014","journal-title":"Endocr Rev"},{"key":"10.1016\/j.purol.2018.08.015_bib0430","doi-asserted-by":"crossref","first-page":"R405","DOI":"10.1530\/ERC-18-0138","article-title":"Advances in adrenal tumors 2018","volume":"25","author":"Crona","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.purol.2018.08.015_bib0435","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1245\/s10434-017-6236-1","article-title":"A novel T-Stage classification system for adrenocortical carcinoma: proposal from the US adrenocortical carcinoma Study Group","volume":"25","author":"Poorman","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.purol.2018.08.015_bib0440","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1002\/cncr.26577","article-title":"Clinical benefits of systemic chemotherapy for patients with metastatic pheochromocytomas or sympathetic extra-adrenal paragangliomas: insights from the Largest single-institutional experience","volume":"118","author":"Ayala-Ramirez","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.purol.2018.08.015_bib0445","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/SLA.0b013e3182367ac3","article-title":"Impact of lymphadenectomy on the oncologic outcome of patients with adrenocortical carcinoma","volume":"255","author":"Reibetanz","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.purol.2018.08.015_bib0450","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1055\/s-0035-1549877","article-title":"Impact of regional lymph node dissection on disease specific survival in adrenal cortical carcinoma","volume":"47","author":"Saade","year":"2015","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.purol.2018.08.015_bib0455","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1245\/s10434-013-3164-6","article-title":"Long-term survival after adrenalectomy for stage I\/II adrenocortical carcinoma (ACC): a retrospective comparative cohort study of laparoscopic versus open approach","volume":"21","author":"Donatini","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.purol.2018.08.015_bib0460","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s13304-017-0448-6","article-title":"Robot-assisted adrenalectomy: indications and drawbacks","volume":"69","author":"Nomine-Criqui","year":"2017","journal-title":"Updates Surg"},{"key":"10.1016\/j.purol.2018.08.015_bib0465","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1007\/s00268-014-2484-4","article-title":"Borderline resectable adrenal cortical carcinoma: a potential role for preoperative chemotherapy","volume":"38","author":"Bednarski Bk","year":"2014","journal-title":"World J Surg"},{"key":"10.1016\/j.purol.2018.08.015_bib0470","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1210\/jc.2017-02591","article-title":"Mitotane monotherapy in patients with advanced adrenocortical carcinoma","volume":"103","author":"Megerle","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.purol.2018.08.015_bib0475","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1200966","article-title":"Combination chemotherapy in advanced adrenocortical carcinoma","volume":"366","author":"Fassnacht","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.purol.2018.08.015_bib0480","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1210\/jc.2006-1544","article-title":"Clinical review: current treatment of malignant pheochromocytoma","volume":"92","author":"Scholz","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.purol.2018.08.015_bib0485","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1245\/s10434-016-5739-5","article-title":"Surgical treatment of malignant pheochromocytoma and paraganglioma: retrospective case series","volume":"24","author":"Strajina","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.purol.2018.08.015_bib0245","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1210\/jc.2012-2356","article-title":"Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas","volume":"97","author":"Ayala-Ramirez","year":"2012","journal-title":"J Clin Endocrinol Metab"}],"updated-by":[{"DOI":"10.1016\/j.purol.2018.08.015","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000}},{"DOI":"10.1016\/j.purol.2019.01.011","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000}}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708718305189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708718305189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:30:41Z","timestamp":1761114641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1166708718305189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":49,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S1166708718305189"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2018.08.015","relation":{},"ISSN":["1166-7087"],"issn-type":[{"value":"1166-7087","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: Recommandations fran\u00e7aises du Comit\u00e9 de Canc\u00e9rologie de l\u2019AFU \u2014 Actualisation 2018\u20142020\u00a0: tumeur de la surr\u00e9nale","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2018.08.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}